US Potential Delay on Menthol Cigarettes Ban to 2024

Regulations by 2FIRSTS.ai

Dec.04.2023

US Potential Delay on Menthol Cigarettes Ban to 2024

The long-awaited ban on menthol cigarettes may be delayed until 2024, according to anonymous officials from public health organizations.

According to a report by NBC News, officials from two national public health organizations dedicated to removing menthol cigarettes from the market have expressed that the long-awaited menthol cigarette ban may not be announced by the end of this year, but instead, it could be delayed until 2024.

These two officials requested anonymity to discuss this decision before any official announcement from the Biden administration. They hinted that this delay could be announced as early as next week.

Officials from the public health organization express concerns that the ban may be postponed until next year, or even delayed until after the November presidential elections.

One official expressed deep concerns, stating that the ban may not be implemented before the 2024 elections.

This official stated, "In election years, everything becomes more challenging as people are more prone to distractions."

The White House declined to comment.

References:

[1] Long-awaited ban on menthol cigarettes could be delayed into 2024, public health groups fear

Also Read:

[1] FDA Plans to Ban Mint Flavored Cigarettes and Fruit-Flavored Cigars

[2] US Court Rejects Logic's Request to Block FDA's Mint-Flavored E-Cigarette Ban

[3] U.S. Court Temporarily Halts Ban on Sales of Vuse Alto Mint-flavored Vapes

#North America #United States #Traditional tobacco #Legislation #Menthol cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

Research Report: E-Cigarette Device Market to Hit $34.29 Billion by 2031; Top Brands Now Hold Nearly Half the Share

Market research firm LP Information has released a global e-cigarette market report forecasting that the e-cigarette device market—including both disposable and reusable devices—will reach US$34.29 billion by 2031, with a 9.4% CAGR from 2025 to 2031.

Oct.16

The Spanish Nicotine Pouches Association (ABN) is officially launched, calling for a clear regulatory framework grounded in scientific evidence

The Spanish Nicotine Pouches Association (ABN) has launched in Madrid, uniting more than 40 companies to call for science-based, proportionate regulation. The group warns that a proposed 0.99 mg nicotine cap could amount to a de facto ban and introduces new voluntary industry standards in response.

Dec.03

Abu Dhabi Closes Two Stores Near Schools Over Vape Sales Violations

The Abu Dhabi Business Registration Authority (ADRA) closed two commercial establishments and issued 61 warnings and 18 fines to outlets near schools for violating tobacco and e-cigarette sales regulations, according to the Emirates News Agency (WAM). The measures aim to protect youth and ensure compliance with the Federal Anti-Tobacco Law.